Successful treatment of advanced gastric cancer by surgical resection following combination chemotherapy with oral S-1 and biweekly paclitaxel

被引:7
作者
Nakajo, Akihiro [1 ]
Natsugoe, Shoji [1 ]
Hokita, Shuichi [1 ]
Ishigami, Sumiya [1 ]
Takatori, Hiroyuki [1 ]
Arigami, Takaaki [1 ]
Uenosono, Yoshikazu [1 ]
Aridome, Kuniaki [1 ]
Aikou, Takashi [1 ]
机构
[1] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Digest Surg & Surg Oncol, Kagoshima 8908520, Japan
关键词
chemotherapy; paclitaxel; S-1; gastric cancer;
D O I
10.1007/s10120-006-0394-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report on the successful treatment of advanced gastric cancer by surgical resection following neoadjuvant chemotherapy. A 67-year-old man was referred to our hospital with a diagnosis of pancreatic cancer. Meticulous examination, however, revealed the presence of gastric cancer with ascites and large lymph node metastasis adjacent to the pancreas. We selected combination chemotherapy with oral S-1 and biweekly paclitaxel. After two courses, both the primary tumor and metastatic lymph nodes were greatly reduced, and the ascites had disappeared. Using laparoscopy, there was no evidence of peritoneal metastases, and the cytological examination was negative. The patient underwent distal gastrectomy with D2 lymph node dissection. Histological examination revealed that the cancer cells were still present in part, but no lymph node metastases were found. The tumor was pathologically diagnosed as pT2, pN0, P0, M0, CY0, and p-stage II. The patient is healthy over 4 years after surgery without recurrence.
引用
收藏
页码:58 / 62
页数:5
相关论文
共 17 条
[1]  
Akatsu Yukako, 2004, Gastric Cancer, V7, P128
[2]   Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer [J].
Hideo Baba ;
Manabu Yamamoto ;
Kazuya Endo ;
Yasuharu Ikeda ;
Yasushi Toh ;
Shunji Kohnoe ;
Takeshi Okamura .
Gastric Cancer, 2003, 6 (Suppl 1) :45-49
[3]   EVIDENCE THAT MICROTUBULE DEPOLYMERIZATION EARLY IN THE CELL-CYCLE IS SUFFICIENT TO INITIATE DNA-SYNTHESIS [J].
CROSSIN, KL ;
CARNEY, DH .
CELL, 1981, 23 (01) :61-71
[4]  
HOKITA S, 2005, CANCER CHEMOTH PHARM, V15, P1
[5]   A phase I study of S-1 combined with weekly cisplatin for metastatic gastric cancer in an outpatient setting [J].
Hyodo, I ;
Nishina, T ;
Moriwaki, T ;
Endo, S ;
Terao, T ;
Hirao, K ;
Nasu, J ;
Hirasaki, S ;
Endo, H ;
Masumoto, T ;
Tajiri, H ;
Kurita, A .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (16) :2328-2333
[6]   Complete response of highly advanced gastric cancer with peritoneal dissemination after new combined chemotherapy of S-1 and low-dose cisplatin: Report of a case [J].
Iwahashi, M ;
Nakamori, M ;
Tani, M ;
Yamaue, H ;
Sakaguchi, S ;
Nakamura, M ;
Ueda, K ;
Ichiro, M ;
Nishino, E ;
Tanimura, H .
ONCOLOGY, 2001, 61 (01) :16-22
[7]  
Japanese Gastric Cancer Association, 1998, Gastric Cancer, V1, P10
[8]   Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer [J].
Koizumi, W ;
Kurihara, M ;
Nakano, S ;
Hasegawa, K .
ONCOLOGY, 2000, 58 (03) :191-197
[9]   Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer [J].
Koizumi, W ;
Tanabe, S ;
Saigenji, K ;
Ohtsu, A ;
Boku, N ;
Nagashima, F ;
Shirao, K ;
Matsumura, Y ;
Gotoh, M .
BRITISH JOURNAL OF CANCER, 2003, 89 (12) :2207-2212
[10]   Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur 0.4 M gimestat 1 M otastat potassium) in advanced gastric cancer patients [J].
Sakata, Y ;
Ohtsu, A ;
Horikoshi, N ;
Sugimachi, K ;
Mitachi, Y ;
Taguchi, T .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (11) :1715-1720